D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 72 Citations 17,608 324 World Ranking 14095 National Ranking 7363

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Dopamine

Michael H. Baumann mostly deals with Pharmacology, Dopamine, Internal medicine, Endocrinology and Serotonin. His Pharmacology research is multidisciplinary, incorporating elements of Monoamine neurotransmitter, Neurochemical and Fenfluramine. His Dopamine study frequently links to related topics such as MDMA.

His work in the fields of Internal medicine, such as Prolactin, intersects with other areas such as Docosahexaenoic acid, Offspring and Unsaturated fatty acid. He interconnects Tyrosine kinase, In vitro and LY294002 in the investigation of issues within Endocrinology. His work on Serotonin transporter is typically connected to Iboga alkaloid as part of general Serotonin study, connecting several disciplines of science.

His most cited work include:

  • Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. (761 citations)
  • Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications. (568 citations)
  • Diagnosis and Management of Cough Executive Summary: ACCP Evidence-Based Clinical Practice Guidelines (539 citations)

What are the main themes of his work throughout his whole career to date?

The scientist’s investigation covers issues in Pharmacology, Dopamine, Internal medicine, Serotonin and Endocrinology. His Pharmacology study deals with Monoamine neurotransmitter intersecting with Cathinone. The concepts of his Dopamine study are interwoven with issues in Methamphetamine and Transporter.

His research investigates the connection with Internal medicine and areas like Oncology which intersect with concerns in Head and neck squamous-cell carcinoma. His Serotonin research incorporates themes from Agonist and MDMA. His work on Neurotoxicity expands to the thematically related Endocrinology.

He most often published in these fields:

  • Pharmacology (40.59%)
  • Dopamine (30.38%)
  • Internal medicine (27.96%)

What were the highlights of his more recent work (between 2018-2021)?

  • Pharmacology (40.59%)
  • Internal medicine (27.96%)
  • Oncology (7.26%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Pharmacology, Internal medicine, Oncology, Radiation therapy and Dopamine. His work carried out in the field of Pharmacology brings together such families of science as Amphetamine, Cathinone and Monoamine neurotransmitter. His research in Amphetamine intersects with topics in Biological activity and MDMA.

His studies deal with areas such as Lateralization of brain function and Neurocognitive, Cognition as well as Internal medicine. His Dopamine research includes elements of Neurochemical, Norepinephrine and Serotonin. Michael H. Baumann has included themes like Methcathinone and Potency in his Serotonin study.

Between 2018 and 2021, his most popular works were:

  • CT imaging during treatment improves radiomic models for patients with locally advanced head and neck cancer. (19 citations)
  • Can Local Ablative Radiotherapy Revert Castration-resistant Prostate Cancer to an Earlier Stage of Disease? (18 citations)
  • Analytical quantification, intoxication case series, and pharmacological mechanism of action for N-ethylnorpentylone (N-ethylpentylone or ephylone). (17 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Dopamine

His main research concerns Pharmacology, Radiation therapy, Internal medicine, Oncology and Dopamine. The various areas that he examines in his Pharmacology study include Metabolite, Dopamine receptor D2 and Opioid. His Radiation therapy research is multidisciplinary, relying on both Biomarker, Positron emission tomography, Flash and Irradiation.

His Proportional hazards model, FMISO and Hypoxia study in the realm of Internal medicine connects with subjects such as Relative Volume. The study incorporates disciplines such as Serotonin transporter and Serotonin in addition to Dopamine. His Methylone study combines topics from a wide range of disciplines, such as Transporter, MDMA, Amphetamine, Ring and Monoaminergic.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin.

Richard B. Rothman;Michael H. Baumann;Christina M. Dersch;Dana V. Romero.
Synapse (2001)

987 Citations

Diagnosis and Management of Cough Executive Summary: ACCP Evidence-Based Clinical Practice Guidelines

Richard S. Irwin;Michael H. Baumann;Donald C. Bolser;Louis Philippe Boulet.
web science (2006)

830 Citations

Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications.

Richard B. Rothman;Michael H. Baumann;Jason E. Savage;Laura Rauser.
Circulation (2000)

728 Citations

Monoamine transporters and psychostimulant drugs.

Richard B. Rothman;Michael H. Baumann.
European Journal of Pharmacology (2003)

505 Citations

The Designer Methcathinone Analogs, Mephedrone and Methylone, are Substrates for Monoamine Transporters in Brain Tissue

Michael H Baumann;Mario A Ayestas;John S Partilla;Jacqueline R Sink.
Neuropsychopharmacology (2012)

418 Citations

Depressive-Like Effects of the κ-Opioid Receptor Agonist Salvinorin A on Behavior and Neurochemistry in Rats

William A. Carlezon;Cécile Béguin;Jennifer A. DiNieri;Michael H. Baumann.
Journal of Pharmacology and Experimental Therapeutics (2006)

417 Citations

Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products.

Michael H Baumann;John S Partilla;Kurt R Lehner;Eric B Thorndike.
Neuropsychopharmacology (2013)

393 Citations

Hyperfractionated Accelerated Chemoradiation With Concurrent Fluorouracil-Mitomycin Is More Effective Than Dose-Escalated Hyperfractionated Accelerated Radiation Therapy Alone in Locally Advanced Head and Neck Cancer: Final Results of the Radiotherapy Cooperative Clinical Trials Group of the German Cancer Society 95-06 Prospective Randomized Trial

Volker Budach;Martin Stuschke;Wilfried Budach;Michael Baumann.
Journal of Clinical Oncology (2005)

365 Citations

3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings

Michael H. Baumann;Xiaoying Wang;Richard B. Rothman.
Psychopharmacology (2006)

281 Citations

N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy').

Michael H Baumann;Robert D Clark;Allison G Budzynski;John S Partilla.
Neuropsychopharmacology (2005)

243 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Michael H. Baumann

Kenner C. Rice

Kenner C. Rice

National Institutes of Health

Publications: 80

Bryan L. Roth

Bryan L. Roth

University of North Carolina at Chapel Hill

Publications: 60

Richard B. Rothman

Richard B. Rothman

National Institute on Drug Abuse

Publications: 48

Anne B. Chang

Anne B. Chang

Boston Children's Hospital

Publications: 45

Yavin Shaham

Yavin Shaham

National Institute on Drug Abuse

Publications: 42

William A. Carlezon

William A. Carlezon

Harvard University

Publications: 39

Harald H. Sitte

Harald H. Sitte

Medical University of Vienna

Publications: 33

Amy Hauck Newman

Amy Hauck Newman

National Institute on Drug Abuse

Publications: 31

Anthony L. Riley

Anthony L. Riley

American University

Publications: 28

Richard A. Glennon

Richard A. Glennon

Virginia Commonwealth University

Publications: 26

Michael Freissmuth

Michael Freissmuth

Medical University of Vienna

Publications: 26

Bruce M. Cohen

Bruce M. Cohen

Harvard University

Publications: 26

Mary Jeanne Kreek

Mary Jeanne Kreek

Rockefeller University

Publications: 25

F. Ivy Carroll

F. Ivy Carroll

Research Triangle Park Foundation

Publications: 25

Craig R. Rush

Craig R. Rush

University of Kentucky

Publications: 25

Félix Carvalho

Félix Carvalho

University of Porto

Publications: 24

Trending Scientists

Rajdeep Grewal

Rajdeep Grewal

University of North Carolina at Chapel Hill

Kenton O'Hara

Kenton O'Hara

Microsoft (United States)

John Newman

John Newman

University of California, Berkeley

A. K. Zvezdin

A. K. Zvezdin

Russian Academy of Sciences

Prescott L. Deininger

Prescott L. Deininger

Tulane University

Takashi Yura

Takashi Yura

Kyoto University

Margaret J. McFall-Ngai

Margaret J. McFall-Ngai

Pacific Biosciences (United States)

Paul A. Randazzo

Paul A. Randazzo

National Institutes of Health

David E. Stallknecht

David E. Stallknecht

University of Georgia

Walter D. Gonzalez

Walter D. Gonzalez

National Institute for Space Research

Hervé Guillou

Hervé Guillou

Centre national de la recherche scientifique, CNRS

Youxue Zhang

Youxue Zhang

University of Michigan–Ann Arbor

Jeff Skousen

Jeff Skousen

West Virginia University

Elek Molnar

Elek Molnar

University of Bristol

Rita Z. Goldstein

Rita Z. Goldstein

Icahn School of Medicine at Mount Sinai

Andrea Falini

Andrea Falini

Vita-Salute San Raffaele University

Something went wrong. Please try again later.